Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-06-12-Speech-2-343"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010612.18.2-343"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – Madam President, first of all I should like to congratulate the European Parliament on the way it has followed up the question on silicone breast implants, which was put to the Committee on Petitions, and in particular the rapporteur Mrs Fourtou. I would say that I was privileged to take part in this procedure and I highly appreciate the respectful and professional way the committee dealt with the issue. It gave a chance to the citizens to come with their serious problems and concerns. The committee wanted to hear the scientific opinion on the issue, the experts, and then draw its conclusions. This is a new departure for our institutions and I hope it will pave the way towards closing the gap between the citizens and the European institutions, a problem which faces all of us.
The draft resolution has a strong independent scientific basis in the report drawn up by Professor Moreno at the request of Parliament. The draft rightly distinguishes between measures to be taken at Community level and those that should be taken mainly at national level as part of health and consumer policy. The draft resolution reflects the consensus between our institutions and Member States, with whom we have been discussing the subject over the last few months and who share our concern to improve the situation that was highlighted in such an impressive way by the petitioners. The Commission will adopt a communication on breast implants within the coming weeks, before the end of July. It is now subject to internal Commission consultation procedures.
Our communication intends to reinforce the implementation of the medical device directive on issues such as conformity assessment, standardisation, monitoring, clinical data etc. It also addresses recommendations to Member States that fall under the chapter of health policy, in particular on the highly important issue of informed patient consent. Women have a right to the fullest possible information regarding the risks and benefits of breast implants before surgery so that they can take a well-informed, deliberate decision. The Commission services had a meeting with the representatives of the petitioners, in particular concerning informed patient consent and we received a number of useful suggestions. The Commission's communication will be sent to Parliament as soon as it is adopted."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples